Your browser doesn't support javascript.
loading
Multifaceted role of SARS-CoV-2 structural proteins in lung injury.
Zheng, Guoping; Qiu, Guanguan; Qian, Huifeng; Shu, Qiang; Xu, Jianguo.
Afiliação
  • Zheng G; Shaoxing Second Hospital, Shaoxing, Zhejiang, China.
  • Qiu G; Shaoxing Second Hospital, Shaoxing, Zhejiang, China.
  • Qian H; Shaoxing Second Hospital, Shaoxing, Zhejiang, China.
  • Shu Q; The Children's Hospital of Zhejiang University School of Medicine and National Clinical Research Center for Child Health, Hangzhou, Zhejiang, China.
  • Xu J; Shaoxing Second Hospital, Shaoxing, Zhejiang, China.
Front Immunol ; 15: 1332440, 2024.
Article em En | MEDLINE | ID: mdl-38375473
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the third human coronavirus to cause acute respiratory distress syndrome (ARDS) and contains four structural proteins spike, envelope, membrane, and nucleocapsid. An increasing number of studies have demonstrated that all four structural proteins of SARS-CoV-2 are capable of causing lung injury, even without the presence of intact virus. Therefore, the topic of SARS-CoV-2 structural protein-evoked lung injury warrants more attention. In the current article, we first synopsize the structural features of SARS-CoV-2 structural proteins. Second, we discuss the mechanisms for structural protein-induced inflammatory responses in vitro. Finally, we list the findings that indicate structural proteins themselves are toxic and sufficient to induce lung injury in vivo. Recognizing mechanisms of lung injury triggered by SARS-CoV-2 structural proteins may facilitate the development of targeted modalities in treating COVID-19.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Lesão Pulmonar / COVID-19 Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Lesão Pulmonar / COVID-19 Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China